| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.00084 | 1 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.00063 | 1 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.00048 | 1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.00077 | 1 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.00047 | 1 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.00055 | 1 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.00022 | 1 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.00014 | 1 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 2.1e-05 | 1 |